Help us: Donate
Follow us on:
×

Menu

Back

Creating Political Action to Increase Healthy Human Lifespan

Bringing politicians on board might be easier than expected.

AL4I PanelAL4I Panel
 

A recent online discussion panel revealed some valuable insights into the political aspects of increasing healthy human lifespans. Perhaps the most exciting part of the panel involves the idea that getting politicians to support longevity/aging therapeutics might not be as hard as people may think.

Giving our field an effective political voice

On December 9th, 2021, the recently launched Alliance for Longevity Initiatives (A4LI) held its first public event! A4LI is an allied, US-based 501(c)(4) nonprofit organization that aims to provide our movement with the political and lobbying voice it needs in the United States. In order to get therapies approved, we need such an organization to engage with politicians and government agencies.

Perhaps surprisingly, there is plenty of interest in increasing healthy human lifespans in political circles, and there is an ongoing effort to standardize the industry to help smooth discussions with politicians and government agencies. The Longevity Biotechnology Association was created last year with this in mind and as a way of separating the credible research happening from the snake oil salesmen that plague it.

Once considered fringe science in past decades, it is nice to see that those days are largely behind us and that the field is increasingly regarded as a legitimate area of scientific research. Hopefully, as more human trials are launched and quality science is conducted, that perception will continue to improve and attract researchers.

Their first panel included former Speaker of the House of Representatives, Newt Gingrich; former Democratic Congressman, Steve Israel; Director of the Institute for Aging Research at Albert Einstein College of Medicine, Nir Barzilai, M.D.; Partner at the SALT Fund, Dina Radenkovic M.D.; and A4LI Chair of the Board, Sonia Arrison. The panel was moderated by A4LI’s Founder and President, Dylan Livingston.

What’s next, and how can you get involved?

Dylan Livingston took a moment to answer some follow-up questions we had from the panel.

It has been suggested that academics are largely on board about doing something about aging, investors are increasingly enthusiastic, and now the target should be policymakers next. What about the emphasis on convincing the public; should this take a backseat until the politicians/agencies are on board?

Dylan – The focus can and should be on both – the community/industry can run a public persuasion campaign while policymakers are being lobbied. A4LI, because of its 501(c)(4) designation, is going to focus mainly on policymakers for right now – that’s an unexplored avenue.

Organizations like Lifespan.io are doing a great job already of public outreach and education. Lifespan.io’s effort to increase public awareness will help A4LI’s ability to lobby politicians (see Steve Israel’s response in our event) and A4LI’s efforts to create pro-longevity politicians will help increase public awareness, which will drive more eyes to organizations like Lifespan.io.

What are the plans for A4LI to drive change at the Food and Drug Administration? Have you considered focusing on expanding the RMAT framework, which caters to cutting-edge medical technologies?

Dylan – Creating a designation pathway for longevity/aging therapeutics, similar to RMAT, is our goal but not what we are pushing to achieve in the short-term.

In the past, some people in our community have contacted politicians about life extension but lacked a clear plan of action, which has harmed our image as a movement. What can someone who already supports the movement do right now to support political progress?

Dylan – Join our mailing list so we can deploy advocates strategically. Let A4LI decide which politicians to target and when.

Support for effective political lobbying is growing

The community appears to agree that an effective political voice is needed for our field. This became evident when A4LI recently raised over $12,000 during the Gitcoin GR12 funding round to help with its lobbying and political efforts.

We spoke to A4LI board member Keith Comito about the launch of the new non-profit life extension lobbying organization.

I am incredibly excited to see the launch of the Alliance for Longevity Initiatives, first announced at the Lifespan.io EARD2021 conference, and to sit on the board of the A4LI myself. If we seriously desire to accelerate the pace of life extension research it is important that we collectively understand the related policy landscape, listen to those who live within it, and learn the ideals means by which positive change can be accomplished. At this event I was overjoyed to hear former Speaker Newt Gingrich and former Representative Steve Israel express a clear and bipartisan sentiment — that it may be easier than once thought to see significant funding applied to addressing the core mechanisms of aging, providing we chose our words with the care such an important mission deserves.

Keith is also the President of Lifespan.io, and on a related note, we are fiscally sponsoring A4LI’s educational resource-related initiatives and you can support this organization with a donation if you would like to help out. You can also contact us if you want to send a wire transfer to support the Alliance for Longevity Initiatives.

Conclusion

As surprising as it might seem, as this panel shows, it may not be as hard as expected to get politicians on board. What it will need is careful planning, effective communication of the facts, and thoughtful dialogue between researchers, lobbyists, and politicians. This is where the A4LI comes in, and it could, at long last, give our movement a much-needed political voice.

Heroes banner

CategoryAdvocacy, News
About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
  1. Neil
    January 6, 2022

    This is good news! It would be great if an event could be organized where we all email our representatives with a unified message.

Write a comment:

Cancel reply

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.